Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 1, 2012, Pages 110-122

  Kiyan, Yulia ^a   Limbourg, Anne ^b   Kiyan, Roman ^a   Tkachuk, Sergey ^a   Limbourg, Florian P ^c   Ovsianikov, Aleksandr ^a,d   Chichkov, Boris N ^a   Haller, Hermann ^e   Dumler, Inna ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Integrated Research and Treatment Center   (Germany)

^c Junior Research Group Regenerative Agents   (Germany)

^d LASER ZENTRUM HANNOVER E V   (Germany)

^e VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

plasminogen activators; receptors; remodeling; urokinase; vascular muscle

Indexed keywords

BIOMATERIAL; LIGAND; MYOCARDIN; PLASMINOGEN ACTIVATOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEASOME; SERUM RESPONSE FACTOR; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY LIGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MODULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTHESIS; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CAROTID ARTERY INJURIES; CELLS, CULTURED; ENDOCYTOSIS; GTPASE-ACTIVATING PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NUCLEAR PROTEINS; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA, SMALL INTERFERING; SUMOYLATION; TRANS-ACTIVATORS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VASCULAR DISEASES;

EID: 83655163681     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.234369     Document Type: Article

References (50)

1. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801. (Pubitemid 38823766)
2. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500-1510. (Pubitemid 46986103)
3. Steins MB, Padro T, Schwaenen C, Ruiz S, Mesters RM, Berdel WE, Kienast J. Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions. Blood Coagul Fibrinolysis. 2004;15:383-391. (Pubitemid 38901608)
4. Binder BR, Mihaly J, Prager GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost. 2007;97: 336-342. (Pubitemid 46437793)
5. Gu J-M, Johns A, Morser J, Dole WP, Greaves DR, Deng GG. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice. J Cell Physiol. 2005;204:73-82. (Pubitemid 40776808)
6. Shushakova N, Eden G, Dangers M, Menne J, Gueler F, Luft FC, Haller H, Dumler I. The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung. J Immunol. 2005;175: 4060-4068. (Pubitemid 41292069)
7. Jo M, Lester RD, Montel V, Eastman B, Takimoto S, Gonias SL. Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling. J Biol Chem. 2009;284:22825-22833.
8. Bernstein AM, Twining SS, Warejcka DJ, Tall E, Masur SK. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell. 2007;18:2716-2727. (Pubitemid 47025736)
9. Kiyan J, Kusch A, Tkachuk S, Kramer J, Dietz R, Smith G, Dumler I. Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor. Atherosclerosis. 2007;195:254-261. (Pubitemid 350087953)
10. Kiyan J, Smith G, Haller H, Dumler I. Urokinase receptor-mediated phenotypic changes of vascular smooth muscle cells require involvement of membrane rafts. Biochem J. 2009;423:343-351.
11. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3:932-943. (Pubitemid 35477371)
12. Kiyan J, Kiyan R, Haller H, Dumler I. Urokinase-induced signaling in human vascular smooth muscle cells are mediated by PDGFR-β. EMBO J. 2005;24:1787-1797. (Pubitemid 40769498)
13. Kiian I, Tkachuk N, Haller H, Dumler I. Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway. Thromb Haemost. 2003;89:904-914. (Pubitemid 36603434)
14. Kusch A, Tkachuk S, Haller H, Dietz R, Gulba DC, Lipp M, Dumler I. Urokinase-dependent activation of phosphatidylinositol 3-kinase: interaction with Tyk2 and requirement for human vascular smooth muscle cell migration. J Biol Chem. 2000;275:39466-39473. (Pubitemid 32058972)
15. Kunigal S, Kusch A, Tkachuk N, Tkachuk S, Jerke U, Haller H, Dumler I. Monocyte-expressed urokinase inhibits vascular smooth muscle cell growth by activating Stat1. Blood. 2003;102:4377-4383. (Pubitemid 37494098)
16. Chen J, Kitchen CM, Streb JW, Miano JM. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol. 2002;34:1345-1356. (Pubitemid 35244412)
17. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003;35:577-593. (Pubitemid 36681543)
18. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001; 105:851-862. (Pubitemid 32635087)
19. Pipes GCT, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 2006;20:1545-1556. (Pubitemid 43901093)
20. Wang Z, Wang DZ, Pipes GC, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA. 2003;100: 7129-7134. (Pubitemid 36706404)
21. Li S, Wang DZ, Wang Z, Richardson JA, Olson EN. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci USA. 2003;100:9366-9370. (Pubitemid 37033934)
22. van Tuyn J, Knaan-Shanzer S, van de Watering MJ, de Graaf M, van der Laarse A, Schalij MJ, van der Wall EE, de Vries AA, Atsma DE. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc Res. 2005;67:245-255. (Pubitemid 40943617)
23. Fallier-Becker P, Rupp J, Fingerle J, Betz E. Smooth muscle cells from rabbit aorta. In: Piper HM, ed. Cell Culture Techniques in Heart and Vessel Research. Berlin, Germany: Springer-Verlag; 1990:247-270.
24. Jerke U, Tkachuk S, Kiyan J, Stepanova V, Kusch A, Hinz M, Dietz R, Haller H, Fuhrman B, Dumler I. Stat1 nuclear translocation upon monocyte differentiation is mediated by nucleolin. PLoS One. 2009;4: e8302.
25. Mukai Y, Rikitake Y, Shiojima I, Wolfrum S, Satoh M, Takeshita K, Hiroi Y, Salomone S, Kim HH, Benjamin LE, Walsh K, Liao JK. Decreased vascular lesion formation in mice with inducible endothelialspecific expression of protein kinase Akt. J Clin Invest. 2006;116: 334-343. (Pubitemid 43228350)
26. Farsari M, Chichkov BN. Materials processing: two-photon fabrication. Nature Photonics. 2009;3:450-452.
27. Serbin J, Egbert A, Ostendorf A, Chichkov BN, Houbertz R, Domann G, Schulz J, Cronauer C, Fröhlich L, Popall M. Femtosecond laser-induced two-photon polymerization of inorganic-organic hybrid materials for applications in photonics. Opt Lett. 2003;28:301-303.
28. Bryer SC, Koh TJ. The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1152-R1158. (Pubitemid 47358936)
29. Lafarga M, Berciano MT, Pena E, Mayo I, Castaño JG, Bohmann D, Rodrigues JP, Tavanez JP, Carmo-Fonseca M. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. Mol Biol Cell. 2002;13:2771-2728.
30. Yin H, Jiang Y, Li H, Li J, Gui Y, Zheng XL. Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells. J Cell Physiol. 2011;226:1897-1906.
31. Xie P, Fan Y, Zhang H, Zhang Y, Mingpeng S, Gu D, Patterson C, Li H. CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation. Mol Cell Biol. 2009;29: 2398-2408.
32. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F.α-2 Macroglobulin receptor/LDL receptor-related protein (LRP-1)-dependent internalization of the urokinase receptor. J Cell Biol. 1995;131:1609-1622.
33. Czekay RP, Kummel TA, Orlando RA, Farquhar MG. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol Biol Cell. 2001;12:1467-1479. (Pubitemid 33044425)
34. Cortese K, Sahores M, Madsen CD, Tacchetti C, Blasi F. Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One. 2008;3:e3730.
35. Takayama Y, May P, Anderson RGW, Herz J. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBLmediated ubiquitination of the platelet-derived growth factor receptorβ(PDGFRβ) . J Biol Chem. 2005;280:18504-18510. (Pubitemid 41389100)
36. Kalab P, Heald R. The RanGTP gradient: a GPS for the mitotic spindle. J Cell Sci. 2008;121:1577-1586. (Pubitemid 351911814)
37. Choudhary S, Berhe M, Haberstroh KM, Webster TJ. Increased endothelial and vascular smooth muscle cell adhesion on nanostructured titanium and CoCrMo. Int J Nanomedicine. 2006;1:41-49.
38. Peng L, Eltgroth M, LaTempa TJ, Grimes CA, Desai TA. The effect of TiO2 nanotubes on endothelial function and smooth muscle proliferation. Biomaterials. 2009;30:1268-1272.
39. Liu ZP, Wang Z, Yanagisawa H, Olson EN. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev Cell. 2005;9:261-270. (Pubitemid 41051744)
40. Li HJ, Haque Z, Lu Q, Li L, Karas R, Mendelsohn M. Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation. Proc Natl Acad Sci. 2007;104: 4065-4070. (Pubitemid 47181579)
41. Olsnes S, Klingenberg O, Wiedlocha A. Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol Rev. 2003;83:163-182. (Pubitemid 36459880)
42. Kelly KF, Otchere AA, Graham M, Daniel JM. Nuclear import of the BTB/POZ transcriptional regulator Kaiso. J Cell Sci. 2004;117: 6143-6152. (Pubitemid 40123978)
43. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price EJ, Roberts RL, Imboden H, Fitzgerald TG, Gaffney FA, Inagami T. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 2003;22:6471-6482. (Pubitemid 38009595)
44. Stepanova V, Lebedeva T, Kuo A, Yarovoi S, Tkachuk S, Zaitsev S, Bdeir K, Dumler I, Marks M, Parfyonova Y, Tkachuk VA, Higazi AAR, Cines. DB. Nuclear translocation of urokinase-type plasminogen activator. Blood. 2008;112:100-110.
45. Steggerda SM, Paschal BM. Regulation of nuclear import and export by the GTPase Ran. Int Rev Cytol. 2002;217:41-91. (Pubitemid 34498930)
46. Carmeliet P, Collen D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res. 1998;91:255-285. (Pubitemid 28454725)
47. Carmeliet P, Moons L, Herbert JM, Crawley J, Lupu F, Lijnen R, Collen D. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res. 1997;81:829-839. (Pubitemid 27467218)
48. Lamfers MLM, Grimbergen JM, Aalders MC, Havenga MJ, de Vries MR, Huisman LGM, van Hinsbergh VW, Quax PHA. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. Circ Res. 2002; 91:945-952. (Pubitemid 35373595)
49. Quax PH, Lamfers ML, Lardenoye JH, Grimbergen JM, de Vries MR, Slomp J, de Ruiter MC, Kockx MM, Verheijen JH, van Hinsbergh VW. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circulation. 2001;103:562-569. (Pubitemid 32116242)
50. Dewerchin M, Nuffelen AV, Wallays G, Bouche A, Moons L, Carmeliet P, Mulligan RC, Collen D. Generation and characterization of urokinase receptor-deficient mice. J Clin Invest. 1996;97:870-878. (Pubitemid 26057107)